News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
168 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17535)
Month
January (3218)
February (3391)
March (3462)
April (3660)
May (4667)
June (3468)
July (2307)
August (2524)
September (2745)
October (3357)
November (3389)
December (2298)
Day
2 (25)
3 (172)
4 (158)
5 (196)
6 (68)
9 (168)
10 (111)
11 (155)
12 (151)
13 (101)
16 (193)
17 (121)
18 (134)
19 (128)
20 (79)
23 (123)
24 (139)
25 (89)
26 (95)
27 (155)
30 (184)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
2
3
4
5
6
9
10
11
12
13
16
17
18
19
20
23
24
25
26
27
30
Press Releases
Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - September 6, 2024
September 9, 2024
·
2 min read
Press Releases
Avalyn Presents Multiple Posters on AP01 for Pulmonary Fibrosis, Including MIST Phase 2b Trial Design and ATLAS Phase 1b Study Post-hoc Analyses, at ERS 2024
September 9, 2024
·
6 min read
Press Releases
Pharmacy compounding veteran A.J. Day becomes CEO of Wilcrest Pharma
September 9, 2024
·
2 min read
Press Releases
RYBREVANT®▼ (amivantamab) plus lazertinib show strong favourable overall survival trend versus osimertinib in EGFR-mutated advanced lung cancer
September 9, 2024
·
14 min read
Press Releases
Akeso’s Ivonescimab Head-to-Head Phase III Data Against Pembrolizumab Unveiled at WCLC 2024
September 9, 2024
·
10 min read
Press Releases
RYBREVANT® (amivantamab-vmjw) plus LAZCLUZE™ (lazertinib) show strong favorable overall survival trend versus osimertinib in EGFR-mutated advanced lung cancer
September 9, 2024
·
32 min read
Press Releases
Avacta to present updated clinical data on AVA6000 at the European Society for Medical Oncology (ESMO) Congress
September 9, 2024
·
2 min read
Press Releases
MacroGenics Announces TAMARACK Phase 2 Data Presentation at ESMO Congress 2024
September 9, 2024
·
6 min read
Press Releases
HUTCHMED Highlights Clinical Data to be Presented at ESMO Congress 2024 and the 2024 World Conference of Lung Cancer
September 9, 2024
·
10 min read
Press Releases
Antennova to Present Latest Data of ATN-037 in a Mini Oral Presentation at ESMO Congress 2024
September 9, 2024
·
3 min read
Previous
3 of 17
Next
